Serum C-reactive protein level is a significant prognostic indicator in patients with advanced urothelial cancer treated with gemcitabine-cisplatin or carboplatin – preliminary results

INTRODUCTION: This study determines prognostic factors in patients with advanced urothelial cancer (UC) treated with gemcitabine-cisplatin or carboplatin (GC). MATERIAL AND METHODS: The clinical records of 30 patients with advanced UC treated with GC were retrospectively reviewed. Twenty-six patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Morizane, Shuichi, Iwamoto, Hideto, Yao, Akihisa, Isoyama, Tadahiro, Sejima, Takehiro, Takenaka, Atsushi
Formato: Artigo
Lenguaje:Inglês
Publicado: Polish Urological Association 2012
Materias:
Urological Oncology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3921783/
https://ncbi.nlm.nih.gov/pubmed/24578930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5173/ceju.2012.02.art1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares